Early research (Phase 1)Ended earlyNCT01816555
What this trial is testing
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Who this might be right for
Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Medical University of South Carolina 1